Topchoice Medical Future Growth
Future criteria checks 1/6
Topchoice Medical is forecast to grow earnings and revenue by 16.7% and 11.2% per annum respectively. EPS is expected to grow by 16.7% per annum. Return on equity is forecast to be 13.3% in 3 years.
Key information
16.7%
Earnings growth rate
16.7%
EPS growth rate
Healthcare earnings growth | 23.1% |
Revenue growth rate | 11.2% |
Future return on equity | 13.3% |
Analyst coverage | Good |
Last updated | 07 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,751 | 723 | 795 | 1,029 | 11 |
12/31/2025 | 3,332 | 620 | 545 | 892 | 12 |
12/31/2024 | 2,984 | 542 | 86 | 885 | 10 |
9/30/2024 | 2,895 | 487 | 350 | 861 | N/A |
6/30/2024 | 2,894 | 506 | 367 | 870 | N/A |
3/31/2024 | 2,880 | 505 | 292 | 813 | N/A |
12/31/2023 | 2,847 | 500 | 335 | 840 | N/A |
9/30/2023 | 2,764 | 545 | 421 | 784 | N/A |
6/30/2023 | 2,763 | 557 | 243 | 704 | N/A |
3/31/2023 | 2,739 | 551 | 382 | 762 | N/A |
12/31/2022 | 2,719 | 548 | 249 | 670 | N/A |
9/30/2022 | 2,784 | 598 | 224 | 771 | N/A |
6/30/2022 | 2,781 | 648 | 394 | 867 | N/A |
3/31/2022 | 2,804 | 705 | 399 | 876 | N/A |
12/31/2021 | 2,781 | 703 | 572 | 939 | N/A |
9/30/2021 | 2,742 | 713 | 673 | 930 | N/A |
6/30/2021 | 2,652 | 698 | 721 | 897 | N/A |
3/31/2021 | 2,523 | 676 | 723 | 907 | N/A |
12/31/2020 | 2,088 | 493 | 538 | 708 | N/A |
9/30/2020 | 1,992 | 466 | 497 | 628 | N/A |
6/30/2020 | 1,838 | 404 | 389 | 545 | N/A |
3/31/2020 | 1,733 | 352 | 332 | 473 | N/A |
12/31/2019 | 1,931 | 466 | 531 | 659 | N/A |
9/30/2019 | 1,803 | 456 | 545 | 624 | N/A |
6/30/2019 | 1,708 | 405 | 517 | 574 | N/A |
3/31/2019 | 1,632 | 365 | 514 | 576 | N/A |
12/31/2018 | 1,546 | 332 | 229 | 469 | N/A |
9/30/2018 | 1,473 | 310 | 218 | 465 | N/A |
6/30/2018 | 1,357 | 263 | N/A | 413 | N/A |
3/31/2018 | 1,246 | 235 | N/A | 353 | N/A |
12/31/2017 | 1,180 | 217 | N/A | 347 | N/A |
9/30/2017 | 1,108 | 193 | N/A | 304 | N/A |
6/30/2017 | 1,006 | 153 | N/A | 241 | N/A |
3/31/2017 | 946 | 143 | N/A | 207 | N/A |
12/31/2016 | 879 | 136 | N/A | 161 | N/A |
9/30/2016 | 844 | 128 | N/A | 123 | N/A |
6/30/2016 | 801 | 128 | N/A | 141 | N/A |
3/31/2016 | 790 | 129 | N/A | 132 | N/A |
12/31/2015 | 763 | 124 | N/A | 191 | N/A |
9/30/2015 | 715 | 142 | N/A | 193 | N/A |
6/30/2015 | 670 | 127 | N/A | 152 | N/A |
3/31/2015 | 612 | 117 | N/A | 143 | N/A |
12/31/2014 | 584 | 110 | N/A | 129 | N/A |
9/30/2014 | 554 | 109 | N/A | 130 | N/A |
6/30/2014 | 518 | 103 | N/A | 123 | N/A |
3/31/2014 | 488 | 103 | N/A | 120 | N/A |
12/31/2013 | 463 | 100 | N/A | 134 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 600763's forecast earnings growth (16.7% per year) is above the savings rate (2.8%).
Earnings vs Market: 600763's earnings (16.7% per year) are forecast to grow slower than the CN market (26.1% per year).
High Growth Earnings: 600763's earnings are forecast to grow, but not significantly.
Revenue vs Market: 600763's revenue (11.2% per year) is forecast to grow slower than the CN market (13.8% per year).
High Growth Revenue: 600763's revenue (11.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 600763's Return on Equity is forecast to be low in 3 years time (13.3%).